Search by Drug Name or NDC

    NDC 76204-0100-60 Ipratropium Bromide 0.5 mg/2.5mL Details

    Ipratropium Bromide 0.5 mg/2.5mL

    Ipratropium Bromide is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ritedose Pharmaceuticals, LLC. The primary component is IPRATROPIUM BROMIDE.

    Product Information

    NDC 76204-0100
    Product ID 76204-100_0cf35356-36b3-3c83-e063-6394a90a3527
    Associated GPIs 44100030102020
    GCN Sequence Number 021700
    GCN Sequence Number Description ipratropium bromide SOLUTION 0.2 MG/ML INHALATION
    HIC3 B60
    HIC3 Description ANTICHOLINERGICS, ORALLY INHALED SHORT ACTING
    GCN 42235
    HICL Sequence Number 000057
    HICL Sequence Number Description IPRATROPIUM BROMIDE
    Brand/Generic Generic
    Proprietary Name Ipratropium Bromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ipratropium Bromide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/2.5mL
    Substance Name IPRATROPIUM BROMIDE
    Labeler Name Ritedose Pharmaceuticals, LLC
    Pharmaceutical Class Anticholinergic [EPC], Cholinergic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075693
    Listing Certified Through 2024-12-31

    Package

    NDC 76204-0100-60 (76204010060)

    NDC Package Code 76204-100-60
    Billing NDC 76204010060
    Package 2 POUCH in 1 CARTON (76204-100-60) / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE
    Marketing Start Date 2011-11-21
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.07927
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description IPRATROPIUM BR 0.02% SOLN
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis